Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)
- Biodexa Pharmaceuticals PLC Unsponsored ADR BDRX 0.46 +6.98%
- Scinai Immunotherapeutics Ltd. Sponsored ADR SCNI 0.75 −16.67%
Biodexa Pharmaceuticals PLC Unsponsored ADR and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Scinai Immunotherapeutics Ltd. Sponsored ADR is the larger, with a market value of $640.0K against $440.0K — 1.5× the size. Biodexa Pharmaceuticals PLC Unsponsored ADR has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Scinai Immunotherapeutics Ltd. Sponsored ADR has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 5 and Scinai Immunotherapeutics Ltd. Sponsored ADR on 3.
Valuation
Profitability
| Metric | BDRX | SCNI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (1,155.70%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 0.00% | (56.36%) |
| Return on assets | 0.00% | 0.00% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack